Cite
HARVARD Citation
Sarfaty, M. et al. (2021). A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract. Cancer medicine. pp. 1074-1083. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sarfaty, M. et al. (2021). A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract. Cancer medicine. pp. 1074-1083. [Online].